ADMA Biologics, Inc.ADMANASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | 168.10% |
| Q3 2025 | -37.12% |
| Q2 2025 | 207.44% |
| Q1 2025 | -139.18% |
| Q4 2024 | 100.64% |
| Q3 2024 | -45.17% |
| Q2 2024 | 2157.98% |
| Q1 2024 | -112.61% |
| Q4 2023 | 46.82% |
| Q3 2023 | 297.81% |
| Q2 2023 | 58.85% |
| Q1 2023 | -99.52% |
| Q4 2022 | 44.45% |
| Q3 2022 | -3.54% |
| Q2 2022 | 50.68% |
| Q1 2022 | 22.27% |
| Q4 2021 | -149.51% |
| Q3 2021 | 58.43% |
| Q2 2021 | 2.91% |
| Q1 2021 | -3.13% |
| Q4 2020 | -35.08% |
| Q3 2020 | -12.06% |
| Q2 2020 | 13.64% |
| Q1 2020 | -25.42% |
| Q4 2019 | 16.84% |
| Q3 2019 | -26.88% |
| Q2 2019 | -30.35% |
| Q1 2019 | 23.98% |
| Q4 2018 | -49.82% |
| Q3 2018 | 15.86% |
| Q2 2018 | 9.29% |
| Q1 2018 | -23.02% |
| Q4 2017 | -37.16% |
| Q3 2017 | -10.99% |
| Q2 2017 | -62.55% |
| Q1 2017 | -49.39% |
| Q4 2016 | 22.84% |
| Q3 2016 | 2.52% |
| Q2 2016 | 7.04% |
| Q1 2016 | -26.72% |